This article may be reprinted free of charge
provided 1) that there is clear attribution to the Orthomolecular
Medicine News Service, and 2) that both the OMNS free subscription link
http://orthomolecular.org/subscribe.html and also the OMNS archive
http://orthomolecular.org/resources/omns/index.shtml are included.
FOR IMMEDIATE RELEASE
Orthomolecular Medicine News Service, May 25, 2010
Vitamin E Research Ignored by Major News Media
(OMNS, May 25, 2010) If you think Medline and Wikipedia are biased,
take a look through your newspapers and magazines. For example, have you
noticed how the news media are quick to publish negative allegations
about vitamin E, but slow to present the positive side?
Here's a check to see if this is so: Have you seen any articles on
the effectiveness of vitamin E therapy reported in your daily newspaper?
* Increasing vitamin E prevents COPD [Chronic obstructive
pulmonary disease, emphysema, chronic bronchitis] (Agler AH et al.
Randomized vitamin E supplementation and risk of chronic lung disease (CLD)
in the Women's Health Study. American Thoracic Society 2010
International Conference, May 18, 2010.) Summary at
* 800 IU vitamin E per day is a successful treatment for fatty
liver disease. (Sanyal AJ, Chalasani N, Kowdley KV et al.
Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis. N
Engl J Med. 2010 May 6;362(18):1675-85.)
* Alzheimer's patients who take 2,000 IU of vitamin E per day live
longer. (Pavlik VN, Doody RS, Rountree SD, Darby EJ. Vitamin E use
is associated with improved survival in an Alzheimer's disease cohort.
Dement Geriatr Cogn Disord. 2009;28(6):536-40.) Summary at
See also: Grundman M. Vitamin E and Alzheimer disease: the basis for
additional clinical trials. Am J Clin Nutr. 2000 Feb;71(2):630S-636S.
Free access to full text at
* Taking 300 IU vitamin E per day reduces lung cancer by 61%.
(Mahabir S, Schendel K, Dong YQ et al. Dietary alpha-, beta-, gamma- and
delta-tocopherols in lung cancer risk. Int J Cancer. 2008 Sep
* 400 to 800 IU of vitamin E daily reduces risk of heart attack by
77%. (Stephens NG et al. Randomized controlled trial of vitamin E in
patients with coronary artery disease: Cambridge Heart Antioxidant Study
(CHAOS). Lancet, March 23, 1996; 347:781-786.)
* 400 IU of Vitamin E per day reduces epileptic seizures in
children by more than 60%. (Ogunmekan AO, Hwang PA. A randomized,
double-blind, placebo-controlled, clinical trial of D-alpha-tocopheryl
acetate [vitamin E], as add-on therapy, for epilepsy in children.
Epilepsia. 1989 Jan-Feb; 30(1):84-9.)
Such effective quantities of vitamin E positively cannot be obtained
from diet alone. 400 IU is over 25 times the adult US RDA for
vitamin E. Is that a lot, or is the government recommendation
Have you seen any article in any major newspaper or
magazine pushing to raise the RDA?
This might be a good time for them to do so: they need the
readership. The New York Times is over a billion dollars in debt.
(1) Newsweek, having lost $40 million in just the last two years,
is now for sale. (2) This could explain why they are so anti-supplement
(and pro-pharmaceutical), since they appear to depend on drug
advertising money to try to keep afloat.
The Orthomolecular Medicine News Service takes no advertising from
anybody and is free of charge. It is not in debt, and it is not for
sale. OMNS will continue to announce and advocate vitamin therapy,
because it works.
If you would like to join in, please consider writing a pro-vitamin
letter to the editor of your local newspaper or favorite magazine. OMNS
would welcome a copy of your correspondence.
For More Information:
These doctors say, Raise the RDA now:
Specifically in regard to vitamin E:
For vitamin C:
For vitamin D:
Nutritional Medicine is Orthomolecular Medicine
Orthomolecular medicine uses safe, effective nutritional therapy to
fight illness. For more information:
The peer-reviewed Orthomolecular Medicine News Service is a
non-profit and non-commercial informational resource.
Editorial Review Board:
Ralph K. Campbell, M.D. (USA)
Carolyn Dean, M.D., N.D. (Canada)
Damien Downing, M.D. (United Kingdom)
Michael Ellis, M.D. (Australia)
Michael Gonzalez, D.Sc., Ph.D. (Puerto Rico)
Steve Hickey, Ph.D. (United Kingdom)
James A. Jackson, Ph.D. (USA)
Bo H. Jonsson, M.D., Ph.D. (Sweden)
Thomas Levy, M.D., J.D. (USA)
Jorge R. Miranda-Massari, Pharm.D. (Puerto Rico)
Erik Paterson, M.D. (Canada)
Gert E. Shuitemaker, Ph.D. (Netherlands)
Andrew W. Saul, Ph.D. (USA), Editor and contact person. Email:
To Subscribe at no charge:
To Unsubscribe from this list: